BEIJING (AP) — Global markets and U.S. stock futures fell Thursday after the Federal Reserve warned the coronavirus pandemic might threaten the modest economic recovery and kept interest rates near zero.
The drop in stocks accelerated in Europe after Germany said its economy shrank by 10% in the second quarter from the previous three-month period. U.S. GDP data is due later Thursday, while the Europe-wide figures will be released Friday.
Lower interest rates and investor optimism about a possible coronavirus vaccine have helped global markets recover most of this year’s losses. But analysts say it might be too early to bet the recovery will persist, given the rising infection numbers in the United States, Brazil and other countries.
On Wednesday, Fed Chairman Jerome Powell warned that rising U.S. cases, which have led some state governments to reimpose anti-disease measures, threaten the modest recovery from the pandemic.
The Fed said it would keep buying $120 billion of Treasury and mortgage bonds every month to encourage borrowing and spending, but Powell said Congress needs to take action. Legislators have yet to agree on aid after $600 in weekly unemployment benefits for millions of Americans run out this week.
“The current situation is all about money in consumer pockets, which is precisely why fiscal policy is so much more important," Stephen Innes of AxiTrader Corp. said in a report.
In Europe, Frankfurt's DAX retreated 2.4% to 12,511 after the GDP figures came in below expectations. Economists note that the second quarter was the economic low point and recent data has shown a relatively strong bounce back since then. Still, the second quarter drop was the sharpest on record for Germany, Europe's largest economy, and suggests the eurozone figures due Friday could also be worse than predicted.
The CAC 40 stock index in France declined 1.2% to 4,900, and the FTSE 100 in London lost 1.6% to 6,036.
On Wall Street, futures for the benchmark S&P 500 index and the Dow Jones Industrial Average were both 0.8% lower.
In Asia, the Shanghai Composite Index lost 0.2% to 3,286.82 and the Nikkei 225 in Tokyo gave up 0.3% to 22,339.23.
The Hang Seng in Hong Kong tumbled .07% to 24,710.59 after data Wednesday showed the territory's economy shrank by 9% in the quarter ending in June.
The Kospi in Seoul advanced 0.2% to 2,267.01 and Sydney's S&P-ASX 200 added 0.7% to 6,051.10. India's Sensex shed 0.6% to 37,847.47.
Also Thursday, Japan reported retail sales rose by a better-than-forecast 13.1% in June over the previous month.
That means retail sales in one of the world's biggest markets were only 0.9% lower than in February before the crisis hit, Tom Learmouth of Capital Economics said in a report.
In the United States, some companies are reporting quarterly results that exceed forecasts, though they still are well below pre-virus levels.
On Wednesday, Advanced Micro Devices rose 12.5% after it reported stronger profit than Wall Street expected. Starbucks gained 3.7% after it reported a loss that wasn't as bad as analysts were expecting. In Europe, Airbus shares were up after it said it had acted aggressively to support cash flow.
Eastman Kodak surged 318.1%, gaining for a second day after the company won a $765 million government loan to launch a new business unit making pharmaceutical components. Shares rose to $33.20 from $2.62 on Monday.
Gold dropped to $1,944.20 per ounce from Wednesday's $1,953.40.
Benchmark U.S. crude lost 62 cents to $40.65 per barrel in electronic trading on the New York Mercantile Exchange. The contract gained 23 cents on Wednesday to $41.27. Brent crude, used to price international oils, shed 53 cents to $43.56 per barrel in London.
The dollar rose to 105.07 yen from 104.90 yen on Wednesday. The euro fell to $1.1753 from $1.1789.
12 Marijuana Stocks to Buy Now
There are now more than 50 publicly-traded companies operating in the cannabis industry. Most of these companies aren't directly growing and selling marijuana themselves, but they do stand to benefit greatly as more states legalize the sale and possession of marijuana. Some of these marijuana stocks are media companies. Others are privately studying the medical uses of marijuana. Yet others are providing tools and software for marijuana growers. As more cannabis companies file IPOs and enter the stock market, it will become increasingly difficult for investors to identify which marijuana stocks will truly benefit from the cannabis boom.
Our subscribers have begun digging through these companies, checking out their financials, business models and long-term growth prospects. They know that some "marijuana stocks" are just empty shell companies that deserve to be penny stocks, but they also recognize there are some legitimate and growing companies that truly stand to benefit from the green rush. As a group, they have added 10 different cannabis stocks to their watchlists and are actively investing in them. More than 1,400 MarketBeat subscribers are now following our top-trending cannabis company.
This slide show lists the 12 pot stocks that MarketBeat subscribers are have added to their watchlists and are actively monitoring.
View the "12 Marijuana Stocks to Buy Now".